Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Weight Loss

8 Stomach Symptoms That Can Be Early Signs of Stomach Cancer

Most stomach aches, indigestion, or bloating are caused by common digestive issues rather than cancer. However, stomach cancer often begins with subtle symptoms that are easy to dismiss, allowing the disease to progress before it is discovered. According to the American Cancer Society, early stomach cancer may cause few or…

Budget and the Bees

A Pharmacist's Guide to Healthy and Sustainable Weight Loss

Every January or every summer before a holiday, the same promises reappear: rapid results, dramatic transformations, a single trick that changes everything. The evidence tells a quieter story. Research consistently shows that the people who lose weight and keep it off are rarely the ones who lose it fastest. They…

inkl

One Prediabetes Subgroup Kept Sliding Toward Diabetes Despite Years of Sustained Weight Loss

One prediabetes subgroup kept progressing toward diabetes despite sustained 8% weight loss and the steepest drop in insulin secretion.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Alison Hammond’s mother inspired her 11-stone weight loss

IN FULL

The Independent UK

Repeated Weight Loss and Regain Was Tied to Four Times More Thigh Muscle Loss in a Four-Year MRI Study

An MRI study of 1,433 adults found weight cyclers lost nearly four times more thigh muscle over four years than people with stable weight.

Medical Daily

If Your Weight Loss Injection Comes From a Compounder, Here Is What to Ask Before the Next Refill

Compounded GLP-1 users face a July 30 FDA comment deadline. Here is how to tell what you are taking and what to ask your pharmacy.

Medical Daily

Intermittent fasting linked to better brain health – but be careful which method you choose, expert warns

HEALTH IN FOCUS: New research suggests a specific intermittent fasting protocol could reduce dementia risk and boost brain health. So should you do it? Harry Bullmore asks the experts

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Daily Oral Weight Loss Pill Outperformed Oral Semaglutide On Weight And Blood Sugar In Type 2 Diabetes

In a 1,698-person trial, orforglipron beat oral semaglutide on A1C and weight in type 2 diabetes. Here is what was measured and what was not.

Medical Daily

What Goes into OPTAVIA's Nutrition Products, and How to Read a Fueling Label

OPTAVIA, a science-backed, coach-guided comprehensive metabolic health system, displays nutrition facts on its Fuelings. This illustrates how that label functions in practice: every category on the FDA panel is documented in the product's public composition.

Medical Daily

Ozempic Side Effects: What New Research Reveals About the Risks and What Happens When You Stop

Ozempic aids in weight loss and diabetes management but raises concerns about side effects and weight regain post-treatment, highlighting the need for informed decision-making and long-term management strategies.

International Business Times UK

Reducing eating hours may cut risk of dementia, research suggests

The findings suggest that weight loss and restricted eating times can ward off age-related cognitive decline, the study’s principle investigator says

The Independent UK

Millions of people are losing weight using GLP-1s. How do the drugs affect their love lives?

Prescribing doctors often warn of the medications’ potential side-effects – but unexpected impacts on romantic relationships are less understood

The Guardian - AU

10 Cancer Warning Signs Oncologists Say Shouldn’t Be Ignored

Most people experience aches, fatigue, or digestive issues from time to time, and in most cases those symptoms have harmless explanations. However, oncologists consistently emphasize that persistent or unexplained changes deserve medical attention rather than being brushed aside. Early detection remains one of the biggest factors influencing successful cancer treatment,…

Budget and the Bees

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk

A new BMJ study links Ozempic and Mounjaro to 37–68% higher hair loss risk. The FDA is evaluating a safety signal. What patients need to know before their next dose.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

‘Ozempic face’ and hair loss: what evidence is there for weight-loss drug side-effects?

Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known

Medical Daily

Millions of Older Americans Are Starting GLP-1 Drugs Under Medicare Without Age-Specific Safety Standards, Experts Say

The Medicare GLP-1 Bridge Program lacks required muscle, bone, and nutrition screening for adults over 65. Geriatric experts say older patients need different standards. Here's why.

Medical Daily

Millions of Older Americans Are Starting GLP-1 Drugs Under Medicare Without Age-Specific Safety Standards, Experts Say

The Medicare GLP-1 Bridge Program lacks required muscle, bone, and nutrition screening for adults over 65. Geriatric experts say older patients need different standards. Here's why.

Medical Daily

GLP-1 Weight-Loss Drugs May Be Thinning Bone: Doctors Are Starting to Have This Conversation with Patients

A July 2026 JCEM study found semaglutide and tirzepatide linked to greater hip bone loss, especially in people without diabetes. Here's what GLP-1 patients need to know now.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

Doctors Sound Alarm as Popular Weight Loss Drugs Wegovy and Mounjaro Are Linked to Sudden Hair Loss

Wegovy and Mounjaro are linked to a higher risk of hair loss in a major study, with researchers pointing to rapid weight loss and possible iron, zinc and biotin deficiencies.

Bored Panda

The New Drug Melting Body Fat From 38% To 22% — And The Side Effect Patients Are Ignoring

A new weight loss drug is drawing serious attention from the medical community, and the comparisons to Ozempic are coming quickly. But researchers are pointing to one difference between the two that is proving difficult to overlook, and it may change how the conversation around weight loss medication develops from…

Medical Daily

Medicare's New GLP-1 Weight Loss Drug Program Launched July 1, but It Expires in 2027 with No Successor in Place

The Medicare GLP-1 Bridge launched July 1, 2026 at $50/month for eligible beneficiaries. It expires December 31, 2027, with the permanent BALANCE replacement indefinitely delayed.

Medical Daily

The First Oral GLP-1 Weight Loss Pill With No Food or Injection Requirements Is Now Available

Eli Lilly's Foundayo (orforglipron) is the first oral GLP-1 obesity pill with no food or water restrictions. FDA approved it April 1, 2026. Here is what patients should know.

Bored Panda

Man Loses 110 Lbs And Joins A Chinese Fat Camp, Says The Most Powerful Part Was Not The Weight

Weight loss content is everywhere. Before and afters, transformation reels, supplement ads disguised as testimonials- the internet is absolutely saturated with it, and most of it follows the same formula. But every now and then someone comes along with a story that cuts through all of that noise because it…

International Business Times UK

'What's Going on With Her?' Serena Williams' Knee Recovery Update Sparks Fan Concern Over Apparent Weight Loss

Serena Williams' latest knee recovery video reassured fans about her rehabilitation, but many instead questioned her apparent weight loss following her Wimbledon withdrawal.

The Independent UK

Weight loss drugs tied to unexpected side effect, study finds

IN FULL

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the American Cancer Society

104 stories

Bridge

77 stories

the US Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.